KODAK's Health Group showcased its Radiation Oncology Beam Dosimetry Package at last week's American Society for Therapeutic Radiology and Oncology (ASTRO) annual meeting in Denver, Colo.
The Radiation Oncology Beam Dosimetry Package works with the company's KODAK 2000RT CR Plus System and is equipped to enable physicists to perform a wide range of beam and IMRT QA procedures-along with the platform's existing ability to capture portal localization, verification and simulation images required for radiation therapy patients, Kodak said.
The 2000RT CR Plus with the addition of the Dosimetry Package and enhanced software, provides radiation therapy enterprises with the ability to go completely filmless, said Sondra I. McFarlane, director, worldwide marketing, oncology solutions.
Features of the software upgrade for the 2000RT CR Plus include:
- DICOM RT Support, which allows the smooth transfer and exchange of information with oncology image management systems and facilitates communication with other DICOM-compatible planning systems and imaging modalities;
- Ability to import treatment planning system DRR images for easy side-by-side comparison with port images;
- Remote annotation allows oncologists to make comments at a remote workstation and save modified images to the database; and
- Powerful search capabilities facilitate the creation of a worklist to improve productivity at sites that do not have their own image management system.
Kodak also highlighted a new agreement with U.S. Oncology, which selected a KODAK DIRECTVIEW PACS System 5, a component of KODAK CARESTREAM Information Management Solutions, as its recommended image management platform for its network of 82 community-based comprehensive cancer centers and 13 radiation-only sites.
The Denver-based Rocky Mountain Cancer Centers has already installed the Kodak system in its 13 offices and five comprehensive cancer centers throughout Colorado. It is the first US Oncology network practice to implement this system and to transition to a completely digital environment for its diagnostic and oncology imaging, said McFarlane.